Nyrada Inc Annual Report 2020

Annual Report FY20 27 Consolidated Statement of Changes in Equity For the Year Ended 30 June 2020 Consolidated Issued capital Reserves Accumulated losses Total deficiency in equity $ $ $ $ Balance at 1 July 2018 37,003 1,016,604 (2,416,276) (1,362,669) Loss for the year - - (4,095,130) (4,095,130) Other comprehensive income - - - - Total comprehensive loss for the year - - (4,095,130) (4,035,130) Share based payments - 503,333 - 503,333 Balance at 30 June 2019 37,003 1,519,937 (6,511,406) (4,954,466) Balance at 1 July 2019 37,003 1,519,937 (6,511,406) (4,954,466) Loss for the year - - (5,773,667) (5,773,667) Other comprehensive income - - - - Total comprehensive loss for the year - - (5,773,667) (5,773,667) Issue of Common Stock 11,400,000 - - 11,400,000 Conversion of convertible note to Common Stock 4,317,750 (762,045) - 3,555,705 Share issue costs (905,296) - - (905,296) Recognition of share based payments - 2,204,324 - 2,204,324 Transfer vested options reserve 757,892 (757,892) - - Total Transactions with the owner and other transfers 15,570,346 684,387 - 16,254,733 Balance at 30 June 2020 15,607,349 2,204,324 (12,285,073) 5,526,600 The above statement of changes in equity should be read in conjunction with the accompanying notes